BELLICUM PHARMACEUTICALS CEO Richard Fair's 2019 pay falls 47% to $1.7M
BELLICUM PHARMACEUTICALS reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
BELLICUM PHARMACEUTICALS reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, four executives at BELLICUM PHARMACEUTICALS received on average a compensation package of $1.1M, a 39% decrease compared to previous year.
Average pay of disclosed executives at BELLICUM PHARMACEUTICALS
Richard A. Fair, Chief Executive Officer, received $1.7M in total, which decreased by 47% compared to 2018. 59% of Fair's compensation, or $1M, was in option awards. Fair also received $128K in non-equity incentive plan, $566K in salary, as well as $18K in other compensation.
Atabak Mokari, Chief Financial Officer, received a compensation package of $1.1M. 60% of the compensation package, or $669K, was in option awards.
Alan K. Smith, Executive Vice President, Technology Operations, earned $792K in 2019, a 18% decrease compared to previous year.
Shane M. Ward, Secretary, received $607K in 2019, which decreases by 40% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 27, 2020.